Citation

L Stranix-Chibanda, S Brummel, J Pilotto, M Mutambanengwe, V Chanaiwa, T Mhembere, M Kamateeka, J Aizire, G Masheto, R Chamanga, M Maluwa, S Hanley, E Joao, G Theron, N Nevrekar, M Nyati, B Santos, L Aurpibul, M Mubiana-Mbewe, R Oliveira, T Anekthananon, P Mlay, K Angelidou, C Tierney, L Ziemba, A Coletti, K McCarthy, M Basar, N Chakhtoura, R Browning, J Currier, MG Fowler, P Flynn, PROMISE study team. Slow Acceptance of Universal Antiretroviral Therapy (ART) Among Mothers Enrolled in IMPAACT PROMISE Studies Across the Globe. AIDS and Behavior. 2019 Sep 01; 23(9):2522-2531. PMID: 31399793; PMCID: PMCID: PMC6766470.

Citation

A Weinberg, Y Huo, D Kacanek, K Patel, DH Watts, D Wara, R Hoffman, J Klawitter, U Christians for the IMPAACT P1025 team. MARKERS OF SPONTANEUOUS PRETERM DELIVERY IN WOMEN LIVING WITH HIV: RELATIONSHIP WITH PROTEASE INHIBITORS AND VITAMIN D. Journal of Acquired Immune Deficiency Syndromes. 2019 May 28; PMID: 31180997.

Citation

J Aizire, A Sikorskii, L Wambuzi Ogwang, R Kawalazira, A Mutebe, I Familiar-Lopez, M Mallewa, T Taha, M Boivin, MG Fowler for the PROMISE_NEURODEV study team. Decreased growth among antiretroviral drug and HIV exposed uninfected versus unexposed children in Malawi and Uganda. AIDS. 2019 Oct 12; PMID: 31634154.

Citation

Eliza D Hompe, Denise L Jacobson, Joshua A Eudailey, Kevin Butler, Whitney Edwards, Justin Pollara, Sean S Brummel, Genevieve G Fouda, Lemeck Chinula, Melvin Kamanga, Aarti Kinikar, Dhayendre Moodley, Maxensia Owor, Mary Glenn Fowler, Sallie R Permar. Maternal Humoral Immune Responses Do Not Predict Postnatal HIV-1 Transmission Risk in Antiretroviral-Treated Mothers from the IMPAACT PROMISE Study. mSphere. 2019 Oct 23; 4(5):e00716-19. PMID: 31645430; PMCID: PMC7407004.

Citation

M Bwakura Dangarembizi, P Samson, EV Capparelli, CB Moore, P Jean-Philippe, SA Spector, N Chakhtoura, A Benns, B Zimmer, L Purdue, C Jackson, C Wallis, JL Libous, EG Chadwick, IMPAACT P1070 Study Team. Establishing Dosing Recommendations for Efavirenz in HIV/TB-Coinfected Children Younger than 3 Years. Journal of Acquired Immune Deficiency Syndromes. 2019 Aug 01; 81(4):473-480. PMID: 31241542; PMCID: PMC6597185.

Citation

Amita Gupta, Grace Montepiedra, Lisa Aaron, Gerhard Theron , Katie McCarthy , Sarah Bradford , Tsungai Chipato, Tichaona Vhembo, Lynda Stranix-Chibanda, Carolyne Onyango-Makumbi, Gaerolwe R Masheto , Avy Violari, Blandina T Mmbaga, Linda Aurpibul, Ramesh Bhosale, Vidya Mave , Vanessa Rouzier, Anneke Hesseling, Katherine Shin, Bonnie Zimmer, Diane Costello, Timothy R Sterling, Nahida Chakhtoura, Patrick Jean-Philippe, Adriana Weinberg, IMPAACT P1078 TB APPRISE Study Team. Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women. New England Journal of Medicine. 2019 Oct 03; 381(14):1333-1346. PMID: 31577875; PMCID: PMC7051859.

Citation

C Onyango-Makumbi, AH Owora, RS Mwiru, A Mwatha, AM Young, D Moodley, HM Coovadia, L Staranix-Chibanda, K Manji, Y Maldonado, P Richardson, P Andrew, K George, W Fawzi, MG Fowler. Extended Prophylaxis With Nevirapine Does Not Affect Growth in HIV-Exposed Infants. Journal of Acquired Immune Deficiency Syndromes. 2019 Dec 01; 82(4):377-385. PMID: 31567725; PMCID: PMC6817404.

Citation

Diana F Clarke, Mark Mirochnick, Edward P Acosta, Edmund Capparelli, Anne Chain, Hedy Teppler, Betsy Smith, Jos Lommerse, International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1110 Study Team. Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110. Journal of Acquired Immune Deficiency Syndromes. 2019 Dec 01; 82(4):392-398. PMID: 31658182; PMCID: PMC6820708.

Citation

T Meyers, P Samson, EP Acosta, J Moye, E Townley, S Bradford, L Marillo, K Denson, L Hovind, T Sise, H Teppler, SR Mathiba, A Hesseling, MF Cotton, P Krogstad, IMPAACT P1101 Team. Pharmacokinetics and safety of a raltegravir-containing regimen in HIV-infected children aged 2-12 years on rifampicin for tuberculosis. AIDS. 2019 Nov 15; 15(33):2197-2203. PMID: 31689263; PMCID: PMC7232968.

Citation

Catherine N Le, Paul Britto, Sean S Brummel, Risa M Hoffman, Jonathan Z Li, Patricia M Flynn, Taha E Taha, Anne Coletti, Mary Glenn Fowler, Ronald J Bosch, Rajesh T Gandhi, Karin L Klingman, James A McIntyre, Judith S Currier. Time to viral rebound and safety after antiretroviral treatment interruption in postpartum women compared with men. AIDS. 2019 Nov 15; 33(14):2149-2156. PMID: 31373919; PMCID: PMC6832824.